Year All20262025202420232022202120202019 February 12, 2025 atai Life Sciences Announces Proposed Public Offering of Common Shares January 28, 2025 atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder January 10, 2025 atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health November 13, 2024 atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates October 15, 2024 atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit September 4, 2024 atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference August 13, 2024 atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates August 13, 2024 atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT) August 7, 2024 atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference June 26, 2024 atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
January 28, 2025 atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder
January 10, 2025 atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health
November 13, 2024 atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
September 4, 2024 atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
August 13, 2024 atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 13, 2024 atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
August 7, 2024 atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
June 26, 2024 atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
